Navigation Links
Align Technology to Announce Fourth Quarter and 2007 Year End Financial Results on January 29, 2008
Date:1/4/2008

SANTA CLARA, Calif., Jan. 4 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN), the inventor of Invisalign(R), a proprietary method of straightening teeth without wires and brackets, announced today that the Company will report fourth quarter and 2007 year end financial results on Tuesday, January 29, 2008, after the close of market. Financial results will be released over PR Newswire and First Call and will be available on the Investor Relations section of the Company's website at http://investor.aligntech.com.

Following the press release, Align Technology executives will host a conference call to review fourth quarter and 2007 year end financial results. The conference call will begin at 4:30 p.m. ET (1:30 p.m. PT) and will also be available as an audio web cast live via the Internet. To access the web cast, please visit the Investor Relations section of Align Technology's website at http://investor.aligntech.com. To access the conference call, please dial 201-689-8341 approximately fifteen minutes prior to the start of the call.

If you are unable to listen to the call, an archived web cast will be available beginning approximately one hour after the call's conclusion and will remain available for approximately 12 months. Additionally, a telephonic replay of the call can be accessed by dialing 877-660-6853 with account number 292 followed by # and conference number 268148 followed by #. The replay must be accessed from international locations by dialing 201-612-7415 and using the same account and conference numbers referenced above. The telephonic replay will be available through 5:30 p.m. ET on February 12, 2008.

Align Technology Executive to Present At JPMorgan Healthcare Conference (corrected time)

In addition, Thomas M. Prescott, president and chief executive officer of Align Technology, is scheduled to speak at the 26th Annual JPMorgan Healthcare Conference. Both the presentation and breakout session, as noted below, will be web cast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the web site for approximately three months. Details follow:

Conference: JPMorgan Healthcare Conference

Date: Wednesday, January 9, 2008

Presentation: 2:30 to 2:55 p.m. Eastern Time (corrected time)

Breakout: 3:00 to 3:25 p.m. Eastern Time (corrected time)

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and older teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.

To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit http://www.invisalign.com or call 1-800-INVISIBLE.

Investor Relations Contact Press Contact

Shirley Stacy Shannon Mangum Henderson

Align Technology, Inc. Ethos Communication, Inc.

(408) 470-1150 (678) 540-9222

sstacy@aligntech.com align@ethoscommunication.com


'/>"/>
SOURCE Align Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. iNOS expression may links chronic biliary inflammation to malignant transformation
2. Breast Cancer Genes Also Raise Mens Risk for Malignancy
3. McGill researchers link enzyme to breast cancer malignancy
4. Dallas Among the First to Offer Probiotic Supplement Align(R)
5. Early Results of Phase 2 Trial of Perifosine (KRX-0401) for the Treatment of Recurrent Malignant Gliomas Presented at the 12th Annual Scientific Meeting of Society for Neuro-Oncology
6. Threshold Pharmaceuticals Announces Corporate Realignment
7. Test gives insight into prognosis in patients with plasma cell malignancies, finds Mayo Clinic study
8. Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry
9. Align Technology to Announce Third Quarter 2007 Financial Results on October 24, 2007
10. WellPoint Announces Realignment of Core Businesses; Names New Executives
11. Align Technology Executive to Present at Upcoming Financial Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: